From: Prevention of pneumococcal diseases in the post-seven valent vaccine era: A European perspective
Country | 3 most prevalent serotypes | Age group |
---|---|---|
Invasive pneumococcal disease | Â | Â |
UK (2008–2009)[30] | 7F, 19A, 1 | <5 years |
France (2008)[23] | 19A, 1, 7F | ≤15 years |
Belgium (2009)[21] | 1, 19A, 7F | <2 years |
Portugal (2006–2008)[25] | 1, 19A, 7F | ≤5 years |
Germany (2009–2010)[26] | 7F, 1, 19A | <2 years |
Greece (2008–2009)[28] | 19A, 7F, 3 | ≤5 years |
Switzerland (2009)[24] | 3, 19A, 7F | <5 years |
Spain (2009–2010)[27] | 1, 19A, 7F | <15 years |
Pneumococcal pneumonia | Â | Â |
Italy (2007–2009)[31] | 1, 19A, 3 | ≤15 years |
Belgium (2009)[21] | 1, 3, 5 | ≤15 years |
AOM | Â | Â |
Germany (2009–2010)[20] | 3, 19A, 19F | Not reported |
Greece (2008–2009)[28] | 19A, 19F, 6A | ≤5 years |